Viatris and Natco have introduced the first US generic version of Nexavar, with the exclusive launch expected to further boost India’s Natco after a healthy financial fourth quarter that was bolstered by revenues from the firm’s recent launch of a Revlimid rival with Teva.
Viatris and Natco have launched the first US Nexavar generic • Source: Shutterstock
Natco Pharma is expecting a further boost after announcing that partner Viatris has launched the first generic version of Nexavar (sorafenib) 200mg tablets in the US.
The Indian firm cited 2021 sales of $69
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
